Elevated serum triglycerides with clozapine resolved with risperidone in four patients

Pharmacotherapy

Volumn 19, Issue 9, 1999, Pages 1099-1101

  Ghaeli, Padideh ^c   Dufresne, Robert L ^a,b  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c 144 Fogarty Hall ^*

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG CHOICE; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; SCHIZOPHRENIA; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; MALE; PSYCHOTIC DISORDERS; RISK FACTORS; RISPERIDONE; TRIGLYCERIDES;

EID: 0032877048     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.13.1099.31586     Document Type: Article

References (13)

1. Ghaeli P, Dufresne RL. Increased serum triglycerides in clozapine treated patients. Am J Health-Syst Pharm 1996;53:2079-81.
2. Cohen S, Chiles J, MacNaughton A. Weight gain associated with clozapine. Am J Psychiatry 1990;147:503-4.
3. Leadbetter R, Shutty M, Pavalonis D, et al. Clozapine induced weight gain: prevalence and clinical relevance. Am J Psychiatry 1992;149:68-72.
4. Bernstein JG. Psychotropic drug induced weight gain: mechanisms and management. Clin Neuropharmacol 1988;11(suppl 1):S194-206.
5. Dufresne RL, Valentine D, Kass DJ. Thioridazine improves affective symptoms in schizophrenic patients. Psychopharmacol Bull 1993;29:249-55.
6. Doss FW. The effects of antipsychotic drugs on body weight: a retrospective review. J Clin Psychiatry 1979;40:528-30.
7. Gaulin, BD, Markowitz, JS, Caley CF, Nesbit LA, Dufresne RL. Clozapine associated dyslipidemia. Am J Psychiatry In press.
8. Spivak B, Roitman S, Vered Y, et al. Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine. Clin Neuropharmacol 1998;21(4):245-50.
9. Drexel H, Amann FW, Beran J, et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 1994;90:2230-5.
10. Zwaan M, Nulzinger DO. Effect of fluvoxamine on total serum cholesterol levels during weight reduction. J Clin Psychiatry 1996;57:346-8.
11. Kamath V, Jones CN, Yip JC, et al. Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women. Diabetes Care 1997;20(11):1697-1701.
12. Najarian D, Osser D, Berman I, Ghaeli P, Dufresne R. Olanzapine increases weight and serum triglycerides. Presented at the 38th annual meeting of the New Clinical Drug Evaluation Unit, Boca Raton, FL, June 11, 1998.
13. Zeneca Pharmaceuticals. Quetiapine fumarate professional information brochure. Wilmington, DE;1997.